The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Com Shares Regulatory News (TYRU)

  • There is currently no data for TYRU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Vamousse coming to Walmart stores in the USA

14 Jan 2014 07:00

RNS Number : 5439X
TyraTech, Inc.
14 January 2014
 



 

14 January 2014

TyraTech Inc

("TyraTech" or the "Company")

 

Vamousse head lice treatment coming to Walmart stores in the USA

 

TyraTech, Inc. (AIM: TYR and TYRU) a life sciences company focusing on nature-derived insect and parasite control products, is pleased to announce its head lice treatment product, Vamousse™, will come to Walmart stores in the USA from the end of March 2014.

 

The USA market for head lice control products is estimated by TyraTech as being worth approximately $150 million per annum. Given the superior efficacy and safety of Vamousse™, TyraTech believes it is in a position to achieve strong penetration of this market for its breakthrough head lice product, reinforcing their confidence in meeting market expectations for 2014 revenues.

 

Bruno Jactel, Chief Executive Officer, said: "I am delighted to report that TyraTech's breakthrough technology and innovative products are capturing the attention of major retailers. This is our most important milestone to date as it will significantly raise the profile of TyraTech's brands in the US, helping us further expand our market penetration and market share. In addition, the fact that Vamousse™ will come to Walmart stores reinforces our strategy of establishing our own brands within the market place.

 

This is an exciting development for TyraTech and we look forward to the future with great confidence."

 

Further information on Vamousse is available on the Company's website at: http://www.tyratech.com/content/company-products/head-lice.asp

 

For further information please contact:

 

TyraTech Inc.Alan Reade, Non-Executive ChairmanBruno Jactel, Chief Executive Officer

Tel: +44 7841978709 Tel: +1 919 415 4340

 

SPARK Advisory Partners Limited, Nominated Adviser

Matt Davis / Mark Brady

Tel: +44203 368 3551

 

Allenby Capital Limited , Joint Broker

Chris Crawford

 

Walbrook, Financial PR and IRBob Huxford /Guy McDougall (Public Relations)Paul Cornelius (Investor Relations)

 

 

Tel: 44 20 3328 5656

 

Tel: +44 20 7933 8792 Tel: +44 20 7933 8794

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUWCGUPCGQW
Date   Source Headline
31st Oct 20183:01 pmRNSResult of Special Meeting, Cancellation from AIM
25th Oct 20187:00 amRNSSpecial Meeting and Acquisition Update
18th Oct 20183:00 pmRNSNominee accounts
9th Oct 20182:23 pmRNSPosting of Proxy Statement and Timetable Update
5th Oct 201810:05 amRNSUpdate
28th Sep 20184:35 pmRNSPrice Monitoring Extension
28th Sep 20182:06 pmRNSSecond Price Monitoring Extn
28th Sep 20182:00 pmRNSPrice Monitoring Extension
28th Sep 201811:05 amRNSSecond Price Monitoring Extn
28th Sep 201811:00 amRNSPrice Monitoring Extension
28th Sep 20189:05 amRNSSecond Price Monitoring Extn
28th Sep 20189:00 amRNSPrice Monitoring Extension
28th Sep 20188:50 amRNSInterim Results
28th Sep 20187:00 amRNSConditional Merger Agreement Signed with AMVAC
23rd May 20187:00 amRNSFinal Results
9th May 20187:00 amRNSProgress in 2018 on products and milestones
3rd May 20187:00 amRNSChange of Adviser
24th Jan 20185:44 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSResult of Tender Offer
11th Jan 20181:08 pmRNSTR-1
9th Jan 20185:01 pmRNSTR-1
5th Jan 20187:00 amRNSResult of Tender Offer
28th Dec 20177:00 amRNSResult of Special Meeting
4th Dec 20177:00 amRNSTender Offer to Shareholders and Notice of Meeting
12th Sep 20177:00 amRNSInterim Results for Six Months Ended 30 June 2017
24th Aug 20177:00 amRNSCOMPANY UPDATE AND DATE OF INTERIM RESULTS
4th Jul 20172:29 pmRNSJoint Development and License Agreement
29th Jun 20177:00 amRNSResult of AGM
7th Jun 20177:00 amRNSTYR TR-1: Notification of major interest in shares
9th May 20177:00 amRNSResults for the Year Ended 31 December 2016
28th Apr 20173:24 pmRNSFurther re Notice of Final Results
22nd Mar 20178:57 amRNSTR-1: Notification of major interest in shares
9th Feb 20177:00 amRNSPre-close Trading Update
19th Sep 20163:59 pmRNSDirector/PDMR Shareholding
15th Sep 20161:18 pmRNSDirectors' Dealings
13th Sep 20167:00 amRNSInterim Results for Six Months Ended 30 June 2016
28th Jul 20167:00 amRNSPre Close Trading Update
8th Jun 20163:22 pmRNSResult of AGM and Board Change
22nd Apr 20161:57 pmRNSDirectors' Dealings
15th Apr 201612:03 pmRNSAward of Share Options
15th Apr 201611:57 amRNSDirectors' Dealings
14th Apr 20167:00 amRNSDirectors' Dealings
11th Apr 20167:00 amRNSAppointment of José Barella as Chairman
4th Apr 20167:00 amRNSNotice of Preliminary Results
3rd Feb 201612:31 pmRNSHolding(s) in Company
1st Feb 20161:08 pmRNSDirector's Dealings
1st Feb 20167:00 amRNSPre-close Trading Update
20th Jan 20167:00 amRNSAppointment of Erica H. Boisvert as CFO
13th Jan 20167:00 amRNSNew Product Range Launch & Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.